Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trial

.

Source: Human Vaccines and Immunotherapeutics - November 18, 2019 Category: Allergy & Immunology Authors: Leilani Sanchez Osamu Matsuoka Satoshi Inoue Takahiro Inoue Ya Meng Takahiro Nakama Kumiko Kato Aseem Pandey Lee-Jah Chang Source Type: research